Why Allegra Does Not Cross the Blood-Brain Barrier: A Deep Dive into Fexofenadine Pharmacology
Allegra (fexofenadine) does not cross the blood-brain barrier (BBB) primarily because it is a substrate for P-glycoprotein (P-gp), an active efflux tr...
Topic
Explore articles about Medical Science.
9 articles
Allegra (fexofenadine) does not cross the blood-brain barrier (BBB) primarily because it is a substrate for P-glycoprotein (P-gp), an active efflux tr...
Alfred Sommer’s net worth is not a figure documented in public financial disclosures or wealth-tracking databases because he is an academic and a phys...
AIDS is treatable through Antiretroviral Therapy (ART), which prevents the virus from replicating and allows the immune system to recover. With consis...
The Academy of Surgical Research is a professional organization dedicated to advancing the science, methodology, and ethical execution of experimental...
Cell-mediated immunity is a specialized immune response that identifies and destroys intracellular pathogens, such as viruses and certain bacteria, as...
Clinical research encompasses a broad spectrum of scientific investigations designed to evaluate the safety, efficacy, and biological impact of medica...
A body temperature of 37.5 degrees Celsius (99.5 degrees Fahrenheit) is typically classified as a low-grade fever or a subfebrile state. While it sits...
Cyclooxygenase-2 (COX-2) inhibitors are a specialized class of nonsteroidal anti-inflammatory drugs (NSAIDs) designed to block the COX-2 enzyme, which...
The exploration of extreme human weight—specifically individuals reaching the milestone of 1,000 pounds or more—uncovers a complex intersection of rar...
Ads help support this site. They may be unavailable because of a connection issue, unavailable inventory, or a content blocker. If you use a blocker, allowing this site would help support our work.